Central Pacific Bank Trust Division Biomarin Pharmaceutical Inc Transaction History
Central Pacific Bank Trust Division
- $723 Billion
- Q1 2025
A detailed history of Central Pacific Bank Trust Division transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 4,350 shares of BMRN stock, worth $239,989. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,350
Previous 4,550
4.4%
Holding current value
$239,989
Previous $299 Million
2.82%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.05 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$981 Million1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$825 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$596 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...